Type
1.
Warndorff. Attempts at integrating the training in leprosy and tuberculosis: Experience, problems and prospects. The Ethiopian journal of health development [Internet]. 1984;1(2). Available from: http://www.ejhd.org/index.php/ejhd/article/download/1318/1007
Type
1.
Mungrue. The Lingering Occurrence of Leprosy in Trinidad in To the 21st Century. Journal of Ancient Diseases & Preventive Remedies [Internet]. 2017;5(1):1-5. Available from: http://www.openaccessjournals.com/scholarly-articles/the-lingering-occurrence-of-leprosy-in-trinidad-in-to-the-21st-century-2329-8731-1000153.pdf
Type
1.
Domple V, Harnalikar M, Wadde S, Gadekar R, Dhande V. Assessment of disability amongst leprosy patients: A cross-sectional study. National Journal of Community Medicine [Internet]. 2017;8(8):482-6. Available from: https://pdfs.semanticscholar.org/3592/2f817736cb6c5211cb6b7151081eda0a2094.pdf
Type
1.
Freitas TS, Fonoff ET, Marquez Neto OR, Kessler IM, Barros LM, Guimaraes RW, et al. Peripheral Nerve Stimulation for Painful Mononeuropathy Secondary to Leprosy: A 12-Month Follow-Up Study. Neuromodulation : journal of the International Neuromodulation Society. 2017;
Type
1.
Zheng Y, Chen L, Zou J, Zhu Z-G, Zhu L, Wan J, et al. The safety of influenza vaccine in clinically cured leprosy patients in China. Human vaccines & immunotherapeutics. 2017;
Type
1.
Almasi S, Aliparasti MR, Naghili B, Yeganeh K, Tavanafar F, Amini-Khiabani S, et al. Analysis of CTLA-4+49A/G gene polymorphism in cases with leprosy of Azerbaijan, Northwest Iran. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2018;:121-7.
Type
1.
Jindal S, Manjari M, Girdhar M. Role of mast cells in leprosy- A study of 62 cases. Journal of evolution of medical and dental sciences [Internet]. 2017;6(75):5328-31. Available from: https://www.jemds.com/data_pdf/shivani%20jindal-%20--sept%2018-.pdf
Type
1.
Talwar, Zaheer, Gupta S, Nandi D, Hada R, Gupta J. Making of an immuno therapeutic cum immuno prophylactic vaccine against leprosy endowed with multiple properties and useful applications. Journal of medical discovery [Internet]. 2017;2(4):1-8. Available from: http://www.e-discoverypublication.com/wp-content/uploads/2017/09/JMD17029.pdf
Type
1.
Abd-Elmaged W, Hassan M, Mostafa M, Ahmed N, Samy E. Lesional levels of superoxide dismutase and malondialdehyde in paucibacillary and multibacillary leprosy patients. Journal of the Egyptian Women’s Dermatologic Society. 2017;14(3):156-60.
Type
1.
Kulkarni. Epidemiological Profile of Leprosy Patients Attending in A Tertiary Care Centre in Post Leprosy Elimination Era. IOSR Journal of Dental and Medical Sciences [Internet]. 2016;15(9):1-5. Available from: https://pdfs.semanticscholar.org/4445/b2dca2ec6bf037e100e3a16c532794af376a.pdf
Pagination
- Previous page
- Page 242
- Next page